@Article{Packard2010,
journal="Archives of Medical Science Special Issues",
issn="1734-1922",
year="2010",
title="Risk factor modification after ACSBenefits of lipid regulation in acute coronary syndrome",
abstract="Lipid lowering therapy with statins has proven beneficial in patients with acute coronary syndrome (ACS). Outcome trials have demonstrated that the high risk of a recurrent coronary event or stroke can be reduced by about 15% using these agents. Further, greater benefit appears to be present when more aggressive treatment regimens (higher statin doses) are followed. Lipoprotein levels measured in the days following an ACS episode may not be a good guide to therapy due the effects of the acute phase response. Other lipid regulating modalities including HDL raising drugs are being explored. Theoretically, these approaches could be beneficial not only in facilitating reverse cholesterol transport but also in altering inflammatory and oxidative pathways. Their utility needs to be tested rigorously in clinical trials.",
author="Packard, Chris J.",
pages="82--82",
url="https://www.termedia.pl/Risk-factor-modification-after-ACS-Benefits-of-lipid-regulation-in-acute-coronary-syndrome,52,14064,1,1.html"
}